52.54

0.07% -0.09

Soleno Therapeutics Inc (SLNO)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$52.63

Aprire:

$52.63

Volume 24 ore:

153.00K

Relative Volume:

0.05

Capitalizzazione di mercato:

$2.72B

Reddito:

$190.41M

Utile/perdita netta:

$20.48M

Rapporto P/E:

235.82

EPS:

0.2228

Flusso di cassa netto:

$46.66M

1 W Prestazione:

+0.66%

1M Prestazione:

+55.81%

6M Prestazione:

-18.17%

1 anno Prestazione:

-21.77%

Intervallo 1D:

$52.56

$52.64

Intervallo di 1 settimana:

$52.21

$52.69

Portata 52W:

$29.43

$90.32

Soleno Therapeutics Inc Stock (SLNO) Company Profile

Nome

Soleno Therapeutics Inc

Settore

Healthcare (1108)

Industria

Biotechnology (623)

Telefono

650-213-8444

Indirizzo

100 MARINE PARKWAY, SUITE 400, REDWOOD CITY, CA

Dipendente

182

Cinguettio

Prossima data di guadagno

2024-11-05

Ultimi documenti SEC

SLNO's Discussions on Twitter

Compare SLNO vs VRTX, REGN, ARGX, ALNY, ONC

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
SLNO Soleno Therapeutics Inc	52.58	2.72B	190.41M	20.48M	46.66M	0.2228
VRTX Vertex Pharmaceuticals Inc	435.03	110.97B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	749.62	79.17B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	799.95	49.73B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	321.99	42.98B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	310.52	34.37B	5.36B	287.73M	924.18M	2.5229

Soleno Therapeutics Inc Stock (SLNO) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-11-18	Iniziato	Wolfe Research	Outperform
2025-10-07	Iniziato	Goldman	Buy
2025-08-20	Iniziato	Wells Fargo	Overweight
2025-06-23	Iniziato	TD Cowen	Buy
2025-03-05	Ripresa	Stifel	Buy
2024-12-02	Reiterato	Robert W. Baird	Outperform
2024-12-02	Reiterato	Stifel	Buy
2024-09-03	Iniziato	H.C. Wainwright	Buy
2024-05-10	Iniziato	Robert W. Baird	Outperform
2024-02-05	Iniziato	Piper Sandler	Overweight
2024-01-23	Iniziato	Stifel	Buy
2023-11-21	Ripresa	Guggenheim	Buy
2020-09-29	Iniziato	Guggenheim	Buy
2020-01-10	Iniziato	Craig Hallum	Buy
2019-12-23	Iniziato	Oppenheimer	Outperform
2018-02-13	Reiterato	Maxim Group	Buy

Mostra tutto

Soleno Therapeutics Inc Borsa (SLNO) Ultime notizie

03:48 AM

SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire

03:48 AM

Apr 12, 2026

SLNO SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026 - PR Newswire

Apr 12, 2026

Trading the Move, Not the Narrative: (SLNO) Edition - Stock Traders Daily

Apr 12, 2026

2026-04-12 | SLNO STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Soleno Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! | NDAQ:SLNO | Press Release - Stockhouse

Apr 12, 2026

Apr 11, 2026

NASDAQ: SLNO: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against Soleno Therapeutics, Inc. - The Globe and Mail

Apr 11, 2026

FinancialContentNASDAQ: SLNO: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against Soleno Therapeutics, Inc. - FinancialContent

Apr 11, 2026

SLNO INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026 - marketscreener.com

Apr 11, 2026

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Soleno Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionSLNO - ACCESS Newswire

Apr 11, 2026

Apr 10, 2026

Soleno Therapeutics, Inc. Notice of May 5, 2026 Application Deadline for Class Action LawsuitContact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline - PR Newswire

Apr 10, 2026

Neurocrine Biosciences, Inc. (NBIX) Soleno Therapeutics, Inc.M&A CallSlideshow (NASDAQ:NBIX) 2026-04-10 - Seeking Alpha

Apr 10, 2026

SLNO Shareholder Alert: Soleno Therapeutics, Inc. Securities Class Action Lawsuit Investors ... - Bluefield Daily Telegraph

Apr 10, 2026

SLNO Shareholder Alert: Soleno Therapeutics, Inc. - GlobeNewswire

Apr 10, 2026

INVESTOR NOTICE: Soleno Therapeutics (SLNO) Investors with Substantial Losses Have Opportunity to Lead Investor Class ActionHagens Berman - Sahm

Apr 10, 2026

TD Cowen Downgrades Soleno Therapeutics to 'Hold' - National Today

Apr 10, 2026

Apr 09, 2026

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Super Micro Computer, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.

Apr 09, 2026

SLNO DEADLINE NOTICE: Soleno Therapeutics, Inc. Investors Encouraged to Contact Kirby McInerney LLP By May 5, 2026 - ACCESS Newswire

Apr 09, 2026

Rosen Law Firm Encourages Soleno Therapeutics Investors to Secure Counsel Before Deadline - National Today

Apr 09, 2026

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Soleno Therapeutics, Inc. Investors with ... - Caledonian Record

Apr 09, 2026

ROSEN, A LEADING LAW FIRM, Encourages Eos Energy Enterprises, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – EOSE - GlobeNewswire Inc.

Apr 09, 2026

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages - GlobeNewswire

Apr 09, 2026

SLNO Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026 - marketscreener.com

Apr 09, 2026

SOLENO LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Announces - GlobeNewswire

Apr 09, 2026

Soleno Therapeutics Investors Seek Lead in Class Action Lawsuit - National Today

Apr 09, 2026

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Soleno Therapeutics, Inc. of Class Action Lawsuit and Upcoming DeadlinesSLNO - PR Newswire

Apr 09, 2026